Updates are available Correction dated 2025-02-24
Click to view Correction: https://doi.org/10.1007/s00223-025-01352-2
-
Authors
Baumann, Sandra https://orcid.org/0009-0001-3408-4228
Sewing, Lilian
Traechslin, Cyril
Verhagen-Kamerbeek, Wilma
Grize, Leticia
Kraenzlin, Marius
Meier, Christian https://orcid.org/0000-0002-0619-821X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02551315 at ClinicalTrials.govDocuments that mention this clinical trial
Serum Pentosidine in Relation to Obesity in Patients with Type 2 Diabetes and Healthy Controls
https://doi.org/10.1007/s00223-024-01338-6
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030 169407)
Schweizerischen Gesellschaft für Endokrinologie und Diabetologie
Roche Diagnostics
University of Basel
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 16 December 2024
First Online: 7 January 2025
Change Date: 19 February 2025
Change Type: Update
Change Details: Fig. 2 has been updated.
Change Date: 24 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00223-025-01352-2
Declarations
:
: Sandra Baumann, Lilian Sewing, Cyril Traechslin, Wilma Verhagen-Kamerbeek, Leticia Grize, Marius Kraenzlin, and Christian Meier have nothing to declare.
: The study was conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed Consent NHANES is conducted by the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS). The NCHS Research Ethics Review Committee reviewed and approved the NHANES study protocol. All participants signed written informed consent.
